[Efficacy and safety of bendamustine-rituximab combination therapy for newly diagnosed indolent B-cell non-Hodgkin's lymphoma and elderly mantle cell lymphoma: a multi-center prospective phase II clinical trial in China].
Wang H, He Q, Liu D, Deng XZ, Ma J, Xie LN, Sun ZL, Liu C, Zhao RR, Lu K, Chu XX, Gao N, Wei HC, Sun YH, Zhong YP, Xing LJ, Zhang HY, Zhang H, Xu WW, Li ZJ.
Wang H, et al. Among authors: zhang h, zhang hy.
Zhonghua Xue Ye Xue Za Zhi. 2023 Jul 14;44(7):550-554. doi: 10.3760/cma.j.issn.0253-2727.2023.07.004.
Zhonghua Xue Ye Xue Za Zhi. 2023.
PMID: 37749033
Free PMC article.
Clinical Trial.
Chinese.